Pediatric aggressive mature b-cell lymphomas, version 2.2020

Kimberly Davies, Matthew Barth, Saro Armenian, Anthony N. Audino, Phillip Barnette, Branko Cuglievan, Hilda Ding, James B. Ford, Paul J. Galardy, Rebecca Gardner, Rabi Hanna, Robert Hayashi, Kovach E. Alexandra E., Andrea Judit Machnitz, Kelly W. Maloney, Lianna Marks, Kristin Page, Anne F. Reilly, Joanna L. Weinstein, Ana C. XavierNicole R. McMillian, Deborah A. Freedman-Cass

Research output: Contribution to journalReview articlepeer-review

Abstract

Pediatric aggressive mature B-cell lymphomas are the most common types of non-Hodgkin lymphoma in children, and they include Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). These diseases are highly aggressive but curable, the treatment is complex, and patients may have many complicated supportive care issues. The NCCNGuidelines for Pediatric Aggressive Mature B-Cell Lymphomas provide guidance regarding pathology and diagnosis, staging, initial treatment, disease reassessment, surveillance, therapy for relapsed/refractory disease, and supportive care for clinicians who treat sporadic pediatric BL and DLBCL.

Original languageEnglish
Pages (from-to)1105-1123
Number of pages19
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume18
Issue number8
DOIs
StatePublished - Aug 2020

Fingerprint Dive into the research topics of 'Pediatric aggressive mature b-cell lymphomas, version 2.2020'. Together they form a unique fingerprint.

Cite this